Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial
Genetics and Aerobic Exercise to Slow Parkinson's Disease (GEARS) Trial
Jay Alberts
200 participants
Aug 23, 2024
INTERVENTIONAL
Conditions
Summary
The proposed multi-site, Genetics and Aerobic Exercise to Slow PD (GEARS) Trial will, for the first time, determine the interplay between genetics and exercise in altering PD progression. In sum, 200 PD patients will be recruited from the Cleveland and Salt Lake City metro areas to participate in the Pedaling for Parkinson's (PFP) community-based exercise program. Participants will exercise at community-based sites 3x/week for 12 months. All participants will undergo genotyping using an array that includes the genome backbone and common risk variants associated to increase risk for multiple neurological disorders including PD.
Eligibility
Inclusion Criteria6
- Adult with a diagnosis of PD by a physician or physician extender
- Hoehn and Yahr stage I-III
- Demonstrate the ability to safely mount and dismount a stationary cycle
- Reliable transportation to the community exercise facility
- Smartphone device for activity data monitoring
- On a stable dose of anti-parkinsonian medication
Exclusion Criteria6
- Participation in disease modifying PD-related clinical trial or study
- Diagnosis of dementia or any neurocognitive impairment that compromises one's ability to provide informed consent.
- Implanted deep brain stimulation electrodes or focused ultrasound for PD management
- Recommendation for medical clearance using the American College of Sports Medicine (ACSM) Preparticipation Health Screen a. If the ACSM screen recommends medical clearance, the participant must obtain medical clearance by their health care provider prior to participation.
- b. Those who choose not to obtain physician clearance will not be eligible for participation.
- e) A musculoskeletal issue (arthritis, osteoporosis, back problem) that would limit one's ability to engage in a cycling intervention f) Neurological disease other than Parkinson's disease (i.e. multiple sclerosis, stroke) g) Current cardiac arrhythmia
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
All community based exercise sessions are: 3x/week for 40 min, which includes a 5-min warm up \& cool down and a 30-minute main exercise set. Exercise parameters will be set by a neurologically trained physical therapist and will be progressed over time with the ultimate goal of the individual reaching moderate-vigorous exercise. Moderate-vigorous exercise for this project is defined as a cadence of 75+ rpms and a target HR of 60-80% of their age-predicted max
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06442033